about
Gq/11-mediated signaling and hypertrophy in mice with cardiac-specific transgenic expression of regulator of G-protein signaling 2Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.Regulation of cardiac gene expression by KLF15, a repressor of myocardin activityThioredoxin and ventricular remodelingThe critical role of Akt in cardiovascular functionSelf-organization and the self-assembling process in tissue engineeringCucurbitacin I Attenuates Cardiomyocyte Hypertrophy via Inhibition of Connective Tissue Growth Factor (CCN2) and TGF- β/Smads SignalingsTranscription factor CHF1/Hey2 suppresses cardiac hypertrophy through an inhibitory interaction with GATA4Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in miceHypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organizationRole of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats.Cardiac ankyrin repeat protein attenuates cardiac hypertrophy by inhibition of ERK1/2 and TGF-β signaling pathways.Granule cargo release from bone marrow-derived cells sustains cardiac hypertrophy.AMP activated protein kinase is indispensable for myocardial adaptation to caloric restriction in mice.Atrogin-1 inhibits Akt-dependent cardiac hypertrophy in mice via ubiquitin-dependent coactivation of Forkhead proteins.GSK-3β/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy.Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.Master redox regulator Trx1 upregulates SMYD1 & modulates lysine methylation.Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets.Cardiac Stim1 Silencing Impairs Adaptive Hypertrophy and Promotes Heart Failure Through Inactivation of mTORC2/Akt Signaling.Mechanical unloading activates FoxO3 to trigger Bnip3-dependent cardiomyocyte atrophy.Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overloadConstitutively active MEK1 rescues cardiac dysfunction caused by overexpressed GSK-3α during aging and hemodynamic pressure overload.Autophagy in load-induced heart disease.Pleiotropic Effects of Myocardial MMP-9 Inhibition to Prevent Ventricular Arrhythmia.Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.Right ventricle in pulmonary hypertension.Gene profiling during regression of pressure overload-induced cardiac hypertrophy.SERCA inhibition limits the functional effects of cyclic GMP in both control and hypertrophic cardiac myocytes.Parathyroid hormone accelerates decompensation following left ventricular hypertrophy.Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors.Glycogen synthase kinase 3beta together with 14-3-3 protein regulates diabetic cardiomyopathy: effect of losartan and tempol.Nanocurcumin–pyrroloquinoline formulation prevents hypertrophy–induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions.Impact of acute and enduring volume overload on mechanotransduction and cytoskeletal integrity of canine left ventricular myocardium.Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.Chronic Akt blockade aggravates pathological hypertrophy and inhibits physiological hypertrophy.The Amino-Terminal Domain of GRK5 Inhibits Cardiac Hypertrophy through the Regulation of Calcium-Calmodulin Dependent Transcription Factors.Endogenous inhibitors of hypertrophy in concentric versus eccentric hypertrophy
P2860
Q21134156-97C5F0E5-1F0F-4CDB-9835-A7824CFF360EQ24302601-14D8421E-2129-49C6-B174-5EEDB670BB33Q24620992-9B79F599-C5EC-402D-A869-3902C7622552Q24683258-84FAF763-B214-4543-8B45-530DA65936A8Q28083829-261E7453-FB15-4E3D-AB2F-30983902D7B5Q28291281-0F654558-1D6E-43E4-AC9F-84C448EC82F0Q28547428-B4489642-B74C-425B-88CC-7401296BE9EBQ28593631-3CAE28B4-580F-4C15-9E65-78889E12E7CDQ28594677-AD5432A0-6326-4C9B-9083-8A9305918CDAQ30469953-F8BA3303-F1DF-4F36-A18B-1503DAD7D9D4Q33577131-21D89DE1-BEB2-4CB1-A2EB-46554687DC34Q34212259-A251A3FA-2F21-49D3-94B3-0E6F2E92F008Q34316779-0FA85FE4-477C-4688-9026-70530CDA88A0Q34519433-8984CBFA-838A-4E5A-828B-5AEBD674CAEEQ34635436-9BB886DD-0ED0-4026-902E-D657D9BB61A8Q36088932-80784390-AA54-4D7D-9FF2-B82B12DB83E6Q36225026-8C99B648-7F50-4D2B-9AD8-689BC626C85CQ36350919-8CED7980-C78A-466B-845C-4906DEB6C47CQ36486897-EB70ABD6-8CCE-4B5A-9A08-4A72CAE00885Q36682368-F22A77A5-9326-438E-9952-183491450E7CQ36732005-306B2C6E-1FD8-4257-8237-21F19053932CQ36791996-1318921C-D120-4AEA-B639-0CCEB3FA6E90Q36824838-C423AE63-5370-49E1-A44A-B3EB07F37875Q37081700-FA5F759C-8BB7-4928-8AB4-CDE0B24B139CQ37174611-6E02DFDB-03DA-446A-9B44-3FB4C9B4829DQ37342393-9B4ED120-8196-4E57-8C28-893158FE90F6Q37501402-23D7A3EA-4C7F-49A2-9F59-F3C31605E490Q37873230-9FDC088C-B031-46E9-8CB8-1B3621DDA3FAQ38112048-67B5DF73-D0DB-4594-81D4-580AF42B2056Q39338987-16ADDCD3-2AC8-47FC-84EC-36B005FC68B2Q39515221-6DF5F806-DD91-41DB-B769-77C2EAB770A7Q41891365-A9781E04-49B9-4474-BD2C-9C93406C7E47Q42011791-D284084F-FFFA-4FE2-8034-D8FF7692D930Q46985474-44E765F5-B8BB-4BF0-86EF-609C3CD5D098Q47160463-7AB30869-3EFD-44E4-97BB-0ED97EA86D96Q48311640-A23C2899-CD88-45A7-A017-EC8B5EABDB30Q51783087-91AF3684-BD6A-420C-B98D-E135472EA613Q52730249-4F918C64-AC88-4124-A42D-205F4A0FBBE1Q54121169-2B5A1ECB-2620-492B-8B65-A249C9BDDC0BQ57805234-7BB6CE80-2ADA-4928-97C7-ABA0FDF8E639
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Negative regulators of cardiac hypertrophy.
@ast
Negative regulators of cardiac hypertrophy.
@en
type
label
Negative regulators of cardiac hypertrophy.
@ast
Negative regulators of cardiac hypertrophy.
@en
prefLabel
Negative regulators of cardiac hypertrophy.
@ast
Negative regulators of cardiac hypertrophy.
@en
P1476
Negative regulators of cardiac hypertrophy
@en
P2093
Stefan E Hardt
P304
P356
10.1016/J.CARDIORES.2004.03.015
P577
2004-08-01T00:00:00Z